期刊文献+

非酒精性脂肪性肝病与慢性乙型肝炎的相互影响及可能机制

Interaction and Possible Mechanism between Non-Alcoholic Fatty Liver Disease and Chronic Hepatitis B
下载PDF
导出
摘要 随着生活水平改善及方式转变,全球非酒精脂肪性肝病发病率逐年上升,未来可能成为肝移植首要原因;同时我国罹患慢性乙型肝炎人口多,其中共病患者数量不容忽视。本文就二者相互影响及可能机制作一概述。 With the improvement of living standards and the change of lifestyle, the incidence of non-alcoholic fatty liver disease is increasing year by year worldwide, which may become the leading cause of liv-er transplantation in the future. At the same time, the population suffering from Chronic B virus liver disease is large in China, and the number of comorbidity patients cannot be ignored. This pa-per gives an overview of the interaction and possible mechanism between them.
出处 《临床医学进展》 2022年第11期10453-10458,共6页 Advances in Clinical Medicine
  • 相关文献

参考文献2

二级参考文献26

  • 1Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK. Hepatic steatosis in chronic hepatitis B and C: predictors,distribution and effect on fibrosis. J Hepato12005; 43:38-44.
  • 2Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444:840-846.
  • 3Meek SE, Nair KS, Jensen MD. Insulin regulation of regional free fatty acid metabolism. Diabetes 1999; 48:10-14.
  • 4Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003; 125:1695-1704.
  • 5Minakari M, Molaei M, Shalmani HM, Alizadeh AH, Jazi AH, Naderi N, Shavakhi A, Mashayekhi R, Zali MR. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors. Eur J Gastroenterol Hepatol 2009; 21: 512-516.
  • 6Rubbia-Brandt L, Leandro G, Spahr L, Giostra E, Quadri R, Mal6 PJ, Negro F. Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3. Histopathology 2001; 39:119-124.
  • 7Peng D, Han Y, Ding H, Wei L, Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors, J Gastroenterol Hepatol 2008; 23: 1082-1088.
  • 8Antunez I, Aponte N, Fermindez-Carbia A, Rodriguez-Perez F, Toro DH. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C. P R Health Sci J 2004; 23:57-60.
  • 9Cindoruk M, Karakan T, Unal S. Hepatic steatosis has no impact on the outcome of treatment in patients with chronic hepatitis B infection. J Clin Gastroentero12007; 41:513-517.
  • 10Moucari R, Mackiewicz V, Lada O, Ripault MP, Castelnau C, Martinot-Peignoux M, Dauvergne A, Asselah T, Boyer N, Bedossa P, Valla D, Vidaud M, Nicolas-Chanoine MH, Marcellin P. Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients. Hepatology 2009; 49:1151-1157.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部